SAN FRANCISCO, Nov. 11, 2025 /PRNewswire/ -- The global interventional oncology market size is expected to reach USD 4.38 billion by 2030, registering a CAGR of 8.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. This significant expansion is primarily fueled by the rising global cancer burden, with new cases estimated at 20 million in 2022 and forecast to surge to over 35 million by 2050, a 77% increase. Other key market drivers include technological advancements in minimally invasive procedures, a growing geriatric population, a heightened focus on early cancer detection, and increasing public and private investments in the field.
Interventional oncology offers a crucial, minimally invasive alternative to traditional cancer treatments like surgery, radiation, and chemotherapy. Utilizing techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, these procedures provide significant benefits for patients, including reduced recovery times and lower complication rates compared to conventional surgery. As the incidence of cancer continues to climb, driven by factors like tobacco use, unhealthy diets, and physical inactivity, the adoption of these advanced interventional methods is expected to accelerate. Their ability to improve patient outcomes and overall quality of life is a major factor driving their increasing popularity and market growth.
Request or download a free sample copy of this report: Interventional Oncology Market
The industry is responding to the urgent need for effective cancer treatments through active strategic initiatives and significant investment. Companies are dedicated to developing advanced solutions to improve patient care; for example, Terumo launched a dedicated global therapeutic interventional oncology team to enhance solutions in this area. Furthermore, both government and private organizations are committing substantial funds to research and development. An illustration of this is the $25.97 million grant received by the Philips-coordinated IMAGIO consortium in 2023 to support research on minimally invasive treatments for cancers such as liver cancer and soft tissue sarcomas. These corporate and governmental efforts are crucial for spurring innovation, increasing the adoption of interventional oncology technologies, and ultimately improving patient outcomes.
Interventional Oncology Market Report Highlights:
- Based on technique, the ablation therapies segment led the market with a 37.1% revenue share in 2024. Techniques such as radiofrequency, microwave, cryoablation, and laser ablation are highly popular due to their minimally invasive nature and effectiveness in targeting tumors while preserving surrounding tissue.
- The tumor ablation segment is projected to grow at the fastest CAGR of 9.06% over the forecast period. This rapid expansion is driven by the increasing adoption of minimally invasive techniques, such as Radiofrequency Ablation (RFA) and Microwave Ablation (MWA). These methods offer precise tumor destruction as alternatives to surgery.
- Based on application, the liver cancer segment held the largest revenue share of 28.0% in 2024, dominating the market. Its high global prevalence drives this; with approximately 866,136 people diagnosed in 2022, it is one of the most common and deadly cancers worldwide.
- North America dominated the global interventional oncology industry in 2024, holding a 41.87% revenue share. This leading position is attributed to several factors, including the high prevalence of cancer, exemplified by the 239,100 people expected to be diagnosed in Canada in 2023.
Read full market research report on Interventional Oncology Market with TOC - Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030
Interventional Oncology Market Segmentation
Grand View Research has segmented the global interventional oncology market based on technique, procedure, application, and region:
Interventional Oncology Market - Techniques Outlook (Revenue, USD Million, 2018 - 2030)
- Ablation Therapies
- Radiofrequency Ablation (RFA)
- Microwave Ablation (MWA)
- Cryoablation
- Laser Ablation
- Irreversible Electroporation (IRE)
- Embolization Therapies
- Transarterial Chemoembolization (TACE)
- Transarterial Radioembolization (TARE)
- Biopsy Techniques
- Core Needle Biopsy
- Fine Needle Aspiration (FNA)
- Targeted Therapy Delivery Systems
- Drug-Eluting Beads
- Radioembolization
- Drug-Eluting Stents
- Injectable Hydrogels and Nanoparticles
- Other Targeted Therapy Systems
- Image-Guided Procedures
- Ultrasound Guidance
- CT Scan Guidance
- MRI Guidance
- Fluoroscopy Guidance
Interventional Oncology Market - Procedure Outlook (Revenue, USD Million, 2018 - 2030)
- Tumor Ablation
- Tumor Biopsy
- Vascular Interventions
- Palliative Care
Interventional Oncology Market - Application Outlook (Revenue, USD Million, 2018 - 2030)
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer
- Breast Cancer
- Other Cancer
Interventional Oncology Market - End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Specialty Clinics
- Others
Interventional Oncology Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Norway
- Denmark
- Sweden
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in the Interventional Oncology Market
- Medtronic plc
- Boston Scientific Corporation
- Johnson & Johnson (Ethicon)
- Teleflex Incorporated
- Cook Medical
- AngioDynamics Inc.
- Stryker Corporation
- Profound Medical
- Terumo Corporation
- Siemens Healthineers
Check out more related studies published by Grand View Research:
•Interventional Cardiology Devices Market - The global interventional cardiology devices market size is expected to reach USD 19.75 Billion by 2033, registering a CAGR of 7.25% from 2025 to 2033, according to a new report by Grand View Research, Inc. Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.
•Oncology Clinical Trials Market - The global oncology clinical trials market size is expected to reach USD 19.49 billion by 2030, registering a CAGR of 5.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The number of people living with cancer is predicted to rise as lung cancer is the largest cause of cancer-related deaths worldwide, with an estimated 1.8 million people diagnosed and around 60,000 new cases of renal cell carcinoma diagnosed in the U.S. each year. Furthermore, it reflects an increasing prevalence of cancer and an increasing demand for efficient cancer treatment.
•Immuno-oncology Clinical Trials Market - The global immuno-oncology clinical trials market size is expected to reach USD 18.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2024 to 2030. The rapidly growing field of Immuno-oncology has emerged as a novel therapeutic area within the oncology ecosystem, transforming the treatment of cancer.
•Magnetoencephalography Market - The global magnetoencephalography market size is estimated to reach USD 569.7 million by 2033, expanding at a CAGR of 7.2% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growing frequency of new product launches and the rise in the incidence of neurological disorders such as epilepsy, and stroke are key drivers to market growth. In addition, the growing geriatric population is also expected to drive market growth since they are more prone to neurodegenerative diseases. According to the World Health Organization, neurological disorders are a leading cause of death, accounting for 12% of all deaths worldwide.
Browse Horizon Databook on Interventional Oncology Market - Global Interventional Oncology Market Size & Outlook
Browse more research insights from GVR - https://www.grandviewresearch.com/research-insights
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Explore Horizon Databook - The world's most expansive market intelligence platform developed by Grand View Research. Gain insights from 30K+ Global & Regional Reports, 120K+ Country Reports, 1.2M+ Market Statistics, 200K+ Company Profiles, and 5 business solutions encompassing ESG and Sustainability Consulting, Procurement Intelligence, Pricing Index and Analysis, and Consumer Analytics.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Blog - https://globalindustryherald.com/
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/interventional-oncology-market-to-reach-4-38-billion-by-2030-at-cagr-8-55---grand-view-research-inc-302611852.html
